Joseph J Krivulka - Net Worth and Insider Trading
Joseph J Krivulka Net Worth
The estimated net worth of Joseph J Krivulka is at least $33 dollars as of 2024-09-19. Joseph J Krivulka is the Director of Aeolus Pharmaceuticals Inc and owns about 333,333 shares of Aeolus Pharmaceuticals Inc (AOLS) stock worth over $33. Details can be seen in Joseph J Krivulka's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph J Krivulka has not made any transactions after 2012-04-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph J Krivulka
Joseph J Krivulka Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph J Krivulka owns 2 companies in total, including Nektar Therapeutics (NKTR) , and Aeolus Pharmaceuticals Inc (AOLS) .
Click here to see the complete history of Joseph J Krivulka’s form 4 insider trades.
Insider Ownership Summary of Joseph J Krivulka
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2005-03-21 | director |
| AOLS | Aeolus Pharmaceuticals Inc | 2013-05-08 | director |
Joseph J Krivulka Latest Holdings Summary
Joseph J Krivulka currently owns a total of 1 stock. Joseph J Krivulka owns 333,333 shares of Aeolus Pharmaceuticals Inc (AOLS) as of April 5, 2012, with a value of $33.
Latest Holdings of Joseph J Krivulka
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AOLS | Aeolus Pharmaceuticals Inc | 2012-04-05 | 333,333 | 0.00 | 33 |
Holding Weightings of Joseph J Krivulka
Joseph J Krivulka Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph J Krivulka has made a total of 0 transactions in Aeolus Pharmaceuticals Inc (AOLS) over the past 5 years. The most-recent trade in Aeolus Pharmaceuticals Inc is the acquisition of 333,333 shares on April 5, 2012, which cost Joseph J Krivulka around $100,000.
Insider Trading History of Joseph J Krivulka
- 1
Joseph J Krivulka Trading Performance
GuruFocus tracks the stock performance after each of Joseph J Krivulka's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph J Krivulka is -10%. GuruFocus also compares Joseph J Krivulka's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph J Krivulka within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph J Krivulka's insider trading performs compared to the benchmark.
Performance of Joseph J Krivulka
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.33 | | | | | |
| Relative Return to S&P 500(%) | 5.4 | | | | | |
Joseph J Krivulka Ownership Network
Joseph J Krivulka Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Joseph J Krivulka is the director of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Joseph J Krivulka made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Joseph J Krivulka Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph J Krivulka. You might contact Joseph J Krivulka via mailing address: C/o Dance Biopharm Inc., 150 North Hill Drive, Suite 24, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
